James E. Bradner
34Patents
10h-index
35Co-inventors
71Inventor score
Filing activity: Mar 22, 2006 → Sep 28, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8148526B1 | Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof | Chemistry; Metallurgy | 32 | Active |
| US8394810B2 | Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof | Chemistry; Metallurgy | 30 | Active |
| US8609678B2 | Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof | Chemistry; Metallurgy | 27 | Active |
| US8754237B2 | Bifunctional histone deacetylase inhibitors | Chemistry; Metallurgy | 17 | Active |
| US8999289B2 | Treatment of protein degradation disorders | Physics | 15 | Active |
| US8222423B2 | Bifunctional histone deacetylase inhibitors | Chemistry; Metallurgy | 12 | Active |
| US8383855B2 | Histone deacetylase inhibitors | Chemistry; Metallurgy | 12 | Active |
| US8440716B2 | Deacetylase inhibitors and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US10849980B2 | Methods to induce targeted protein degradation through bifunctional molecules | Emerging Cross-Sectional Technologies | 12 | Active |
| US8304451B2 | Histone deacetylase and tubulin deacetylase inhibitors | Chemistry; Metallurgy | 10 | Active |
| US8716344B2 | Class- and isoform-specific HDAC inhibitors and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US9572854B2 | Treatment of protein degradation disorders | Physics | 5 | Active |
| US11583586B2 | Methods to induce targeted protein degradation through bifunctional molecules | Emerging Cross-Sectional Technologies | 3 | Active |
| US10172905B1 | Treatment of protein degradation disorders | Physics | 3 | Active |
| US11059801B2 | Methods to induce targeted protein degradation through bifunctional molecules | Chemistry; Metallurgy | 2 | Active |
| US9199923B2 | Histone deacetylase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US11285218B2 | Degradation of bromodomain-containing protein 9 (BRD9) by conjugation of BRD9 inhibitors with E3 ligase ligand and methods of use | Chemistry; Metallurgy | 2 | Active |
| US9434686B2 | Deacetylase inhibitors and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9540317B2 | Class- and isoform-specific HDAC inhibitors and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US11311609B2 | Regulating chimeric antigen receptors | Chemistry; Metallurgy | 1 | Active |
| US9724321B2 | Histone deacetylase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9567301B2 | Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11293023B2 | Tunable endogenous protein degradation | Chemistry; Metallurgy | 0 | Active |
| US12023385B2 | Tunable endogenous protein degradation with heterobifunctional compounds | Chemistry; Metallurgy | 0 | Active |
| US10059657B2 | Class-and isoform-specific HDAC inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.